HIF1A and breast carcinoma: In the present study, we investigated the ability of baicalein to resensitize TAM‐resistant breast cancer cells both in vitro and in vivo, and explored the potential mechanisms underlying HIF‐1α–mediated aerobic glycolysis and mitochondrial dysfunction.